{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:19:28Z","timestamp":1790705968666,"version":"4.1.0"},"reference-count":74,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2020,11,1]]},"DOI":"10.1001\/jamapediatrics.2020.0824","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T22:23:55Z","timestamp":1589235835000},"page":"1102","source":"Crossref","is-referenced-by-count":57,"title":["HIV Preexposure Prophylaxis Among Adolescents in the US"],"prefix":"10.1001","volume":"174","author":[{"given":"Hasiya","family":"Yusuf","sequence":"first","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol","family":"Fields","sequence":"additional","affiliation":[{"name":"Division of General Pediatrics and Adolescent Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Arrington-Sanders","sequence":"additional","affiliation":[{"name":"Division of General Pediatrics and Adolescent Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Griffith","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Division of Infectious Diseases, Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Agwu","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Division of Infectious Diseases, Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9839","key":"prv200004r3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0140-6736(12)61235-5","article-title":"FDA paves the way for pre-exposure HIV prophylaxis.","volume":"380","author":"Holmes","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"prv200004r4","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jamapediatrics.2017.2007","article-title":"Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States.","volume":"171","author":"Hosek","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"3","key":"prv200004r7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.2105\/AJPH.2015.302979","article-title":"Young people and HIV: a call to action.","volume":"106","author":"Koenig","year":"2016","journal-title":"Am J Public Health"},{"issue":"2","key":"prv200004r11","doi-asserted-by":"publisher","first-page":"F8","DOI":"10.1111\/desc.2007.10.issue-2","article-title":"Risk-taking and the adolescent brain: who is at risk?","volume":"10","author":"Galvan","year":"2007","journal-title":"Dev Sci"},{"key":"prv200004r12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.dcn.2017.07.007","article-title":"Beyond stereotypes of adolescent risk taking: placing the adolescent brain in developmental context.","volume":"27","author":"Romer","year":"2017","journal-title":"Dev Cogn Neurosci"},{"issue":"8","key":"prv200004r13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6708a1","article-title":"Youth risk behavior surveillance\u2014United States, 2017.","volume":"67","author":"Kann","year":"2018","journal-title":"MMWR Surveill Summ"},{"issue":"12","key":"prv200004r14","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2018.1917","article-title":"HIV Preexposure Prophylaxis: A Review.","volume":"319","author":"Riddell","year":"2018","journal-title":"JAMA"},{"key":"prv200004r15","doi-asserted-by":"publisher","first-page":"S393","DOI":"10.1093\/ofid\/ofy210.1121","article-title":"Adolescents\u2019 knowledge and acceptance of pre-exposure prophylaxis (PrEP) in the Capital District region of New York.","volume":"5","author":"Santos","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"prv200004r16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/QAI.0000000000001837","article-title":"HIV pre-exposure prophylaxis engagement among adolescent men who have sex with men: the role of parent-adolescent communication about sex.","volume":"79","author":"Thoma","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"prv200004r17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/QAI.0000000000001164","article-title":"PrEP uptake, adherence, and discontinuation among California YMSM using geosocial networking applications.","volume":"74","author":"Holloway","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"prv200004r18","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1007\/s10461-017-1739-0","article-title":"Use of pre-exposure prophylaxis (PrEP) in young men who have sex with men is associated with race, sexual risk behavior and peer network size.","volume":"21","author":"Kuhns","year":"2017","journal-title":"AIDS Behav"},{"issue":"6","key":"prv200004r19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jadohealth.2016.08.006","article-title":"A medical care missed opportunity: preexposure prophylaxis and young black men who have sex with men.","volume":"59","author":"Arrington-Sanders","year":"2016","journal-title":"J Adolesc Health"},{"issue":"5","key":"prv200004r20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jadohealth.2016.12.004","article-title":"Young transgender women\u2019s attitudes toward HIV pre-exposure prophylaxis.","volume":"60","author":"Wood","year":"2017","journal-title":"J Adolesc Health"},{"issue":"8","key":"prv200004r21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/apc.2014.0303","article-title":"Minimal awareness and stalled uptake of pre-exposure prophylaxis (PrEP) among at risk, HIV-negative, black men who have sex with men.","volume":"29","author":"Eaton","year":"2015","journal-title":"AIDS Patient Care STDS"},{"issue":"12","key":"prv200004r22","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.annepidem.2018.06.005","article-title":"The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.","volume":"28","author":"Siegler","year":"2018","journal-title":"Ann Epidemiol"},{"issue":"23","key":"prv200004r25","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/jama.2019.2592","article-title":"Screening for HIV infection in asymptomatic, nonpregnant adolescents and adults: updated evidence report and systematic review for the US Preventive Services Task Force.","volume":"321","author":"Chou","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"prv200004r26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/2325957414557268","article-title":"Why physicians don\u2019t ask: interpersonal and intrapersonal barriers to HIV testing-making a case for a patient-initiated campaign.","volume":"15","author":"Arya","year":"2016","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"4","key":"prv200004r27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/2325957413517140","article-title":"In the routine HIV testing era, primary care physicians in community health centers remain unaware of HIV testing recommendations.","volume":"13","author":"Arya","year":"2014","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"5","key":"prv200004r28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jadohealth.2018.10.300","article-title":"Primary care physician attitudes and intentions toward the use of HIV Pre-exposure prophylaxis in adolescents in one metropolitan region.","volume":"64","author":"Mullins","year":"2019","journal-title":"J Adolesc Health"},{"issue":"2","key":"prv200004r29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jadohealth.2018.03.016","article-title":"Adolescent health providers\u2019 willingness to prescribe pre-exposure prophylaxis (PrEP) to youth at risk of HIV infection in the United States.","volume":"63","author":"Hart-Cooper","year":"2018","journal-title":"J Adolesc Health"},{"issue":"5","key":"prv200004r30","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s10461-015-0996-z","article-title":"Knowledge is power! increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP.","volume":"19","author":"Blumenthal","year":"2015","journal-title":"AIDS Behav"},{"issue":"4","key":"prv200004r31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/apc.2014.0273","article-title":"Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents.","volume":"29","author":"Mullins","year":"2015","journal-title":"AIDS Patient Care STDS"},{"issue":"9","key":"prv200004r32","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1007\/s10461-014-0839-3","article-title":"HIV providers\u2019 perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study.","volume":"18","author":"Krakower","year":"2014","journal-title":"AIDS Behav"},{"issue":"4","key":"prv200004r33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jadohealth.2018.07.021","article-title":"HIV pre-exposure prophylaxis medication for adolescents and young adults: a position paper of the Society for Adolescent Health and Medicine.","volume":"63","author":"Society for Adolescent Health and Medicine","year":"2018","journal-title":"J Adolesc Health"},{"issue":"6","key":"prv200004r34","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.ajem.2018.11.015","article-title":"Do confidentiality concerns impact pre-exposure prophylaxis willingness in emergency department adolescents and young adults?","volume":"37","author":"Moore","year":"2019","journal-title":"Am J Emerg Med"},{"issue":"1","key":"prv200004r35","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.amepre.2012.09.044","article-title":"State adolescent consent laws and implications for HIV pre-exposure prophylaxis.","volume":"44","author":"Culp","year":"2013","journal-title":"Am J Prev Med"},{"issue":"1","key":"prv200004r36","first-page":"5","article-title":"Pre-exposure prophylaxis as HIV prevention in high risk adolescents.","volume":"2","author":"Gray","year":"2018","journal-title":"J Pediatr Med"},{"issue":"7(Suppl 6)","key":"prv200004r40","doi-asserted-by":"publisher","first-page":"21107","DOI":"10.7448\/IAS.19.7.21107","article-title":"Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa.","volume":"19","author":"Hosek","year":"2016","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"prv200004r41","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/cid\/ciw701","article-title":"Uptake of HIV preexposure prophylaxis among commercially insured persons\u2014United States, 2010-2014.","volume":"64","author":"Wu","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"11","key":"prv200004r42","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1007\/s10461-018-2045-1","article-title":"Why I quit pre-exposure prophylaxis (PrEP); a mixed-method study exploring reasons for PrEP discontinuation and potential re-initiation among gay and bisexual men.","volume":"22","author":"Whitfield","year":"2018","journal-title":"AIDS Behav"},{"issue":"6","key":"prv200004r44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178170","article-title":"Optimal costs of HIV pre-exposure prophylaxis for men who have sex with men.","volume":"12","author":"McKenney","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"prv200004r45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1089\/apc.2017.0255","article-title":"A mobile health strategy to support adherence to antiretroviral preexposure prophylaxis.","volume":"32","author":"Fuchs","year":"2018","journal-title":"AIDS Patient Care STDS"},{"issue":"8","key":"prv200004r46","doi-asserted-by":"crossref","DOI":"10.2196\/10365","article-title":"University of North Carolina\/Emory Center for Innovative Technology (iTech) for addressing the HIV epidemic among adolescents and young adults in the United States: protocol and rationale for center development.","volume":"7","author":"Hightow-Weidman","year":"2018","journal-title":"JMIR Res Protoc"},{"issue":"27","key":"prv200004r47","doi-asserted-by":"publisher","first-page":"597","DOI":"10.15585\/mmwr.mm6827a1","article-title":"Changes in HIV preexposure prophylaxis awareness and use among men who have sex with men\u201420 urban areas, 2014 and 2017.","volume":"68","author":"Finlayson","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"prv200004r48","doi-asserted-by":"publisher","first-page":"21326","DOI":"10.7448\/IAS.20.1.21326","article-title":"A novel online-to-offline (O2O) model for pre-exposure prophylaxis and HIV testing scale up.","volume":"20","author":"Anand","year":"2017","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"prv200004r49","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jadohealth.2018.01.001","article-title":"Hookup app use, sexual behavior, and sexual health among adolescent men who have sex with men in the United States.","volume":"62","author":"Macapagal","year":"2018","journal-title":"J Adolesc Health"},{"issue":"1","key":"prv200004r50","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.jadohealth.2014.09.012","article-title":"Effective strategies to provide adolescent sexual and reproductive health services and to increase demand and community support.","volume":"56","author":"Denno","year":"2015","journal-title":"J Adolesc Health"},{"issue":"4","key":"prv200004r51","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/heapro\/day042","article-title":"Celebrity endorsed music videos: innovation to foster youth health promotion.","volume":"34","author":"Macnab","year":"2019","journal-title":"Health Promot Int"},{"issue":"1","key":"prv200004r53","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.amepre.2016.01.009","article-title":"School-based health centers to advance health equity: a community guide systematic review.","volume":"51","author":"Knopf","year":"2016","journal-title":"Am J Prev Med"},{"issue":"2","key":"prv200004r54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055012","article-title":"Effects of community participation on improving uptake of skilled care for maternal and newborn health: a systematic review.","volume":"8","author":"Marston","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"prv200004r55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/15504280802084506","article-title":"Families of gay, lesbian, and bisexual youth.","volume":"4","author":"D\u2019augelli","year":"2008","journal-title":"J GLBT Fam Stud"},{"issue":"8","key":"prv200004r56","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1080\/00918369.2011.598409","article-title":"Learning about a child\u2019s gay or lesbian sexual orientation: parental concerns about societal rejection, loss of loved ones, and child well being.","volume":"58","author":"Conley","year":"2011","journal-title":"J Homosex"},{"issue":"5","key":"prv200004r57","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jadohealth.2015.07.007","article-title":"Mother-son communication about sex and routine human immunodeficiency virus testing among younger men of color who have sex with men.","volume":"57","author":"Bouris","year":"2015","journal-title":"J Adolesc Health"},{"issue":"4","key":"prv200004r58","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jadohealth.2013.11.004","article-title":"Impact of parent-child communication interventions on sex behaviors and cognitive outcomes for black\/African-American and Hispanic\/Latino youth: a systematic review, 1988-2012.","volume":"54","author":"Sutton","year":"2014","journal-title":"J Adolesc Health"},{"issue":"3","key":"prv200004r59","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1089\/lgbt.2015.0031","article-title":"Experiences of antihomosexual attitudes and young black men who have sex with men in the south: a need for community-based interventions.","volume":"3","author":"Geter","year":"2016","journal-title":"LGBT Health"},{"issue":"5","key":"prv200004r61","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s10461-016-1512-9","article-title":"The importance of sexual history taking for PrEP comprehension among young people of color.","volume":"21","author":"Golub","year":"2017","journal-title":"AIDS Behav"},{"issue":"4","key":"prv200004r64","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/QAI.0b013e318256b2f6","article-title":"Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States.","volume":"60","author":"Smith","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"prv200004r65","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jana.2007.01.002","article-title":"Practice brief: adolescents and HIV clinical trials: ethics, culture, and context.","volume":"18","author":"MacQueen","year":"2007","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"5","key":"prv200004r66","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jadohealth.2016.01.007","article-title":"Inclusion of adolescents in clinical trials for sexually transmitted infections: a review of existing registered studies.","volume":"58","author":"Hoffman","year":"2016","journal-title":"J Adolesc Health"},{"issue":"2","key":"prv200004r67","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/1556264618755919","article-title":"\u201cWhere did this [PrEP] come from?\u201d African American mother\/daughter perceptions related to adolescent preexposure prophylaxis (PrEP) utilization and clinical trial participation.","volume":"13","author":"Fletcher","year":"2018","journal-title":"J Empir Res Hum Res Ethics"},{"issue":"5","key":"prv200004r68","first-page":"396","article-title":"Guidelines for adolescent health research: a position paper of the Society for Adolescent Medicine.","volume":"33","author":"Santelli","year":"2003","journal-title":"J Adolesc Health"},{"issue":"2","key":"prv200004r69","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/cid\/cix755","article-title":"Comparison of measures of adherence to human immunodeficiency virus preexposure prophylaxis among adolescent and young men who have sex with men in the United States.","volume":"66","author":"Koss","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"prv200004r70","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40264-017-0505-6","article-title":"Pre-exposure prophylaxis for HIV prevention: safety concerns.","volume":"40","author":"Tetteh","year":"2017","journal-title":"Drug Saf"},{"issue":"3","key":"prv200004r71","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/cid\/ciw765","article-title":"Decline in bone mass with tenofovir disoproxil fumarate\/emtricitabine is associated with hormonal changes in the absence of renal impairment when used by HIV-uninfected adolescent boys and young men for HIV preexposure prophylaxis.","volume":"64","author":"Havens","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"6","key":"prv200004r73","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/lgbt.2017.0244","article-title":"Acceptability of injectable and on-demand pre-exposure prophylaxis among an online sample of young men who have sex with men in California.","volume":"5","author":"Beymer","year":"2018","journal-title":"LGBT Health"},{"issue":"23","key":"prv200004r74","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand PrEP in men at high risk for HIV-1 infection.","volume":"373","author":"Molina","year":"2015","journal-title":"N Engl J Med"},{"key":"prv200004r1","unstructured":"US Food and Drug Administration approves expanded indication for Truvada (emtricitabine and tenofovir disoproxil fumarate) for reducing the risk of acquiring HIV-1 in adolescents. Published May 15, 2018. Accessed October 8, 2019. https:\/\/www.gilead.com\/news-and-press\/press-room\/press-releases\/2018\/5\/us-food-and-drug-administration-approves-expanded-indication-for-truvada-emtricitabine-and-tenofovir-disoproxil-fumarate-for-reducing-the-risk-of-"},{"key":"prv200004r2","unstructured":"FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic. Published October 3, 2019. Accessed October 8, 2019. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-second-drug-prevent-hiv-infection-part-ongoing-efforts-end-hiv-epidemic"},{"key":"prv200004r5","unstructured":"Centers for Disease Control and Prevention. HIV Surveillance Report. Diagnoses of HIV infection in United States and dependent areas, 2018 (preliminary). Accessed October 4, 2019. https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc-hiv-surveillance-report-2018-vol-30.pdf"},{"key":"prv200004r6","unstructured":"CDC Fact Sheet. Trends in US HIV diagnoses. 2005-2014. Published February 2016. Accessed December 10, 2019. https:\/\/www.cdc.gov\/nchhstp\/newsroom\/docs\/factsheets\/hiv-data-trends-fact-sheet-508.pdf"},{"key":"prv200004r8","unstructured":"Centers for Disease Control and Prevention. Epidemiology of HIV infection. 2018 (preliminary). Accessed October 4, 2019. https:\/\/www.cdc.gov\/hiv\/pdf\/library\/slidesets\/cdc-hiv-surveillance-epidemiology-2018.pdf"},{"key":"prv200004r9","unstructured":"Centers for Disease Control and Prevention. HIV among youth. Published 2019. Accessed December 9, 2019 https:\/\/www.cdc.gov\/hiv\/group\/age\/youth\/index.html"},{"key":"prv200004r10","unstructured":"UNICEF. Adolescent HIV prevention. Updated July 2019. Accessed June 12, 2019. https:\/\/data.unicef.org\/topic\/hivaids\/adolescents-young-people\/"},{"key":"prv200004r23","unstructured":"AIDS 2018. Magnuson? D, Hawkins? T, Mera? T. Adolescent use of Truvada for HIV preexposure prophylaxis (PrEP) in the United States (2012-2017). Accessed June 21, 2019. http:\/\/programme.aids2018.org\/Abstract\/Abstract\/2621"},{"key":"prv200004r24","unstructured":"Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the US; a clinical practice guideline\u20142017 update. Published March 2018. Accessed December 10, 2019. https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2017.pdf"},{"key":"prv200004r37","unstructured":"Centers for Disease Control and Prevention. Minors\u2019 consent laws. 2018. Accessed October 28, 2019. https:\/\/www.cdc.gov\/hiv\/policies\/law\/states\/minors.html"},{"key":"prv200004r38","unstructured":"The HIPAA privacy rule and adolescents: legal questions and clinical challenges. Guttmacher Institute. Published April 19, 2004. Accessed June 11, 2019. https:\/\/www.guttmacher.org\/journals\/psrh\/2004\/hipaa-privacy-rule-and-adolescents-legal-questions-and-clinical-challenges"},{"key":"prv200004r39","unstructured":"Confidentiality for individuals insured as dependents. A review of state laws and policies. Guttmacher Institute. Published January 27, 2016. Accessed December 10, 2019. https:\/\/www.guttmacher.org\/report\/confidentiality-individuals-insured-dependents-review-state-laws-and-policies"},{"key":"prv200004r43","unstructured":"Gilead Sciences. US patient access: Gilead patient assistance programs. Accessed July 2, 2019. https:\/\/www.gilead.com\/purpose\/medication-access\/us-patient-access"},{"key":"prv200004r52","unstructured":"Centers for Disease Control and Prevention. AIDS ambassadors and influencers. 2019. Accessed October 23, 2019. https:\/\/www.cdc.gov\/actagainstaids\/partnerships\/ambassadors-influencers.html"},{"key":"prv200004r60","unstructured":"Centers for Disease Control and Prevention. A guide to taking a sexual history. 2019. Accessed December 18, 2019. https:\/\/www.cdc.gov\/std\/treatment\/sexualhistory.pdf"},{"key":"prv200004r62","unstructured":"Department of Health and Human Services. Ending the HIV epidemic: a plan for America. Published February 2019. Accessed July 2, 2019. https:\/\/www.hhs.gov\/sites\/default\/files\/ending-the-hiv-epidemic-fact-sheet.pdf"},{"key":"prv200004r63","unstructured":"ICAP. Pre-exposure prophylaxis (PrEP) training for providers in clinical settings. Accessed December 18, 2019. https:\/\/icap.columbia.edu\/wp-content\/uploads\/Pre-Exposure-Prophylaxis-PrEP-Training-for-Providers_3.20.19.pdf"},{"key":"prv200004r72","unstructured":"Hare CB, Coll J, Ruane P, et al. The phase 3 Discover Study: daily F\/TAF or F\/TDF for HIV preexposure prophylaxis [abstract 104]. Conference on Retroviruses and Opportunistic Diseases; March 4-7, 2019; Seattle, WA. Accessed October 29, 2019. http:\/\/www.croiconference.org\/sessions\/phase-3-discover-study-daily-ftaf-or-ftdf-hiv-preexposure-prophylaxis"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2765823\/jamapediatrics_yusuf_2020_rv_200004_1604090519.9993.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T16:05:43Z","timestamp":1604333143000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2765823"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":74,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2020.0824","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,1]]}}}